Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer

Genome Integrity

Volumn 3, Issue , 2012, Pages

  Facista, Alexander ^a   Nguyen, Huy ^a   Lewis, Cristy ^a   Prasad, Anil R ^a,b   Ramsey, Lois ^a   Zaitlin, Beryl ^c   Nfonsam, Valentine ^a   Krouse, Robert S ^a,d,e   Bernstein, Harris ^a,d   Payne, Claire M ^a,d,f   Stern, Stephen ^a   Oatman, Nicole ^a   Banerjee, Bhaskar ^a   Bernstein, Carol ^e  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Saint Marys Hospital   (United States)

^c Matrix Solutions Inc   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e Southern Arizona Veterans Affairs Heath Care System   (United States)

^f Biomedical Diagnostics and Research   (United States)

Author keywords

Cancerization; Colon cancer; DNA repair; Ercc1; Field defect; Genomic instability; Ku86; Mutation; Pms2; Xpf

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MISMATCH REPAIR PROTEIN PMS2; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP F PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; COLON BIOPSY; COLON CANCER; COLON MUCOSA; COLON RESECTION; COLONOSCOPY; CONTROLLED STUDY; DNA REPAIR; EARLY CANCER; FEMALE; GENE EXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VILLOUS ADENOMA;

EID: 84861809793     PISSN: None     EISSN: 20419414     Source Type: Journal    
DOI: 10.1186/2041-9414-3-3     Document Type: Article

References (62)

1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6:963-968. 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q, 13094644.
2. Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H. Field defects in progression to gastrointestinal tract cancers. Cancer Lett 2008, 260:1-10. 10.1016/j.canlet.2007.11.027, 2744582, 18164807.
3. Rubin H. Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture. Bioessays 2011, 33:224-231. 10.1002/bies.201000067, 21254148.
4. Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, Saltz LB, Wong WD. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 2008, 26:380-385. 10.1200/JCO.2007.14.1291, 18202413.
5. Nicolas P, Kim KM, Shibata D, Tavaré S. The stem cell population of the human colon crypt: analysis via methylation patterns. PLoS Comput Biol 2007, 3:e28. 10.1371/journal.pcbi.0030028, 1808490, 17335343.
6. Willis ND, Przyborski SA, Hutchison CJ, Wilson RG. Colonic and colorectal cancer stem cells: progress in the search for putative biomarkers. J Anat 2008, 213:59-65. 10.1111/j.1469-7580.2008.00917.x, 2475556, 18638071.
7. Calabrese P, Tavaré S, Shibata D. Pretumor progression: clonal evolution of human stem cell populations. Am J Pathol 2004, 164:1337-1346. 10.1016/S0002-9440(10)63220-8, 1615336, 15039221.
8. Calabrese P, Tsao JL, Yatabe Y, Salovaara R, Mecklin JP, Järvinen HJ, Aaltonen LA, Tavaré S, Shibata D. Colorectal pretumor progression before and after loss of DNA mismatch repair. Am J Pathol 2004, 164:1447-1453. 10.1016/S0002-9440(10)63231-2, 1615342, 15039232.
9. Kim KM, Shibata D. Methylation reveals a niche: stem cell succession in human colon crypts. Oncogene 2002, 21:5441-5449. 10.1038/sj.onc.1205604, 12154406.
10. Greaves LC, Preston SL, Tadrous PJ, Taylor RW, Barron MJ, Oukrif D, Leedham SJ, Deheragoda M, Sasieni P, Novelli MR, Jankowski JA, Turnbull DM, Wright NA, McDonald SA. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci USA 2006, 103:714-719. 10.1073/pnas.0505903103, 1325106, 16407113.
11. Nooteboom M, Johnson R, Taylor RW, Wright NA, Lightowlers RN, Kirkwood TB, Mathers JC, Turnbull DM, Greaves LC. Age-associated mitochondrial DNA mutations lead to small but significant changes in cell proliferation and apoptosis in human colonic crypts. Aging Cell 2010, 9:96-99. 10.1111/j.1474-9726.2009.00531.x, 2816353, 19878146.
12. Bernstein C, Facista A, Nguyen H, Zaitlin B, Hassounah N, Loustaunau C, Payne CM, Banerjee B, Goldschmid S, Tsikitis VL, Krouse R, Bernstein H. Cancer and age related colonic crypt deficiencies in cytochrome c oxidase I. World J Gastrointest Oncol 2010, 2:429-442. 10.4251/wjgo.v2.i12.429, 3011097, 21191537.
13. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008, 135:1079-1099. 10.1053/j.gastro.2008.07.076, 2866182, 18773902.
14. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113. 10.1126/science.1145720, 17932254.
15. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, Parsons DW, Jones S, Sjöblom T, Park BH, Parsons R, Willis J, Dawson D, Willson JK, Nikolskaya T, Nikolsky Y, Kopelovich L, Papadopoulos N, Pennacchio LA, Wang TL, Markowitz SD, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci USA 2008, 105:16224-16229. 10.1073/pnas.0808041105, 2571022, 18852474.
16. Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 2011, 711:167-173. 10.1016/j.mrfmmm.2011.02.015, 21419141.
17. Chang CL, Marra G, Chauhan DP, Ha HT, Chang DK, Ricciardiello L, Randolph A, Carethers JM, Boland CR. Oxidative stress inactivates the human DNA mismatch repair system. Am J Physiol Cell Physiol 2002, 283:C148-C154.
18. Langie SAS, Knaapen AM, Houben JMJ, van Kempen FC, de Hoon JPJ, Gottschalk RWH, Godschalk RWL, van Schooten FJ. The role of glutathione in the regulation of nucleotide excision repair during oxidative stress. Toxicol Lett 2007, 168:302-309. 10.1016/j.toxlet.2006.10.027, 17207589.
19. Bernstein H, Prasad A, Holubec H, Bernstein C, Payne CM, Ramsey L, Katerina Dvorakova K, Wilson M, Warneke JA, Garewal H. Reduced Pms2 expression in non-neoplastic flat mucosa from patients with colon cancer correlates with reduced apoptosis competence. Appl Immunohistochem Mol Morphol 2006, 14:166-172. 10.1097/01.pai.0000170533.61579.b9, 16785784.
20. Bernstein C, Bernstein H, Payne CM, Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 2002, 511:145-178. 10.1016/S1383-5742(02)00009-1, 12052432.
21. Rigas B, Borgo S, Elhosseiny A, Balatsos V, Manika Z, Shinya H, Kurihara N, Go M, Lipkin M. Decreased expression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis. Cancer Res 2001, 61:8381-8384.
22. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005, 352:1851-1860. 10.1056/NEJMoa043146, 15872200.
23. Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 2000, 275:18424-18431. 10.1074/jbc.M001140200, 10747992.
24. Sansom OJ, Bishop SM, Court H, Dudley S, Liskay RM, Clarke AR. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. DNA Repair 2003, 2:1029-1039. 10.1016/S1568-7864(03)00111-3, 12967659.
25. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, Wang JYJ. Interaction of mismatch repair protein Pms2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci USA 2003, 100:2420-2425. 10.1073/pnas.0438031100, 151356, 12601175.
26. Narayanan L, Fritzell JA, Baker SM, Liskay RM, Glazer PM. Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc Natl Acad Sci USA 1997, 94:3122-3127. 10.1073/pnas.94.7.3122, 20332, 9096356.
27. Reardon JT, Bessho T, Kung HC, Bolton PH, Sancar A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in Xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1997, 94:9463-9468. 10.1073/pnas.94.17.9463, 23224, 9256505.
28. Ahmad A, Robinson AR, Duensing A, van Drunen E, Beverloo HB, Weisberg DB, Hasty P, Hoeijmakers JHJ, Niedernhofer LJ. ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Mol Cell Biol 2008, 19:5166-5169.
29. Rahn JJ, Adair GM, Nairn RS. Multiple roles of ERCC1-XPF in mammalian interstrand crosslink repair. Environ Mol Mutagen 2010, 51:567-581.
30. Cummings M, Higginbottom K, McGurk CJ, Wong OG, Köberle B, Oliver RT, Masters JR. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair. Biochem Pharmacol 2006, 72:166-175. 10.1016/j.bcp.2006.04.025, 16756962.
31. Dolle MET, Busuttil RA, Garcia AM, Wijnhoven S, van Drunen E, Niedernhoffer LJ, van der Horst G, Hoeijmakers JHJ, van Steeg H, Vijg J. Increased genomic instability is not a prerequisite for shortened lifespan in DNA repair deficient mice. Mutat Res 2006, 596:22-35. 10.1016/j.mrfmmm.2005.11.008, 16472827.
32. Doig J, Anderson C, Lawrence NJ, Selfridge J, Brownstein DG, Melton DW. Mice with skin-specific DNA repair gene (Ercc1) inactivation are hypersensitive to ultraviolet irradiation-induced skin cancer and show more rapid actinic progression. Oncogene 2006, 25:6229-6238. 10.1038/sj.onc.1209642, 16682947.
33. Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, Schnell TG, Chejfec G, Campbell DR, Kidao J, Bond JH, Nelson DB, Triadafilopoulos G, Ramirez FC, Collins JF, Johnston TK, McQuaid KR, Garewal H, Sampliner RE, Esquivel R, Robertson D. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007, 133:1077-1085. 10.1053/j.gastro.2007.07.006, 17698067.
34. Nara K, Nagashima F, Yasui A. Highly elevated ultraviolet-induced mutation frequency in isolated Chinese Hamster Cell Lines defective in nucleotide excision repair and mismatch repair proteins. Cancer Res 2001, 61:50-52.
35. Nguyen H, Loustaunau C, Facista A, Ramsey L, Hassounah N, Taylor H, Krouse R, Payne CM, Tsikitis VL, Goldschmid S, Banerjee B, Perini RF, Bernstein C. Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer. J Vis Exp 2010, 41. doi:10.3791/1931.
36. Hounnou G, Destrieux C, Desmé J, Bertrand P, Velut S. Anatomical study of the length of the human intestine. Surg Radiol Anat 2002, 24:290-294. 10.1007/s00276-002-0057-y, 12497219.
37. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010, 11:220-228. 10.1038/nrm2858, 20177397.
38. Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO, Bannwart F, Yurtsever H, Neuweiler J, Riehle HM, Cattaruzza MS, Heinimann K, Schär P, Jiricny J, Marra G. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 2005, 128:1160-1171. 10.1053/j.gastro.2005.01.056, 15887099.
39. Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, Mcllhatton MA, Amadori D, Fishel R, Croce CM. Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci USA 2010, 107:6982-6987. 10.1073/pnas.1002472107, 2872463, 20351277.
40. Klase Z, Winograd R, Davis J, Carpio L, Hildreth R, Heydarian M, Fu S, McCaffrey T, Meiri E, Ayash-Rashkovsky M, Gilad S, Bentwich Z, Kashanchi F. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 2009, 6:18. 10.1186/1742-4690-6-18, 2654423, 19220914.
41. Microcosm Targets. , http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/
42. McGurk CJ, Cummings M, Köberle B, Hartley JA, Oliver RT, Masters JR. Regulation of DNA repair gene expression in human cancer cell lines. J Cell Biochem 2006, 97:1121-1136. 10.1002/jcb.20711, 16315315.
43. Biggerstaff M, Szymkowski DE, Wood RD. Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro. EMBO J 1993, 12:3685-3692. 413645, 8253090.
44. van Vuuren AJ, Appeldoorn E, Odijk H, Yasui A, Jaspers NG, Bootsma D, Hoeijmakers JH. Evidence for a repair enzyme complex involving ERCC1 and complementing activities of ERCC4, ERCC11 and xeroderma pigmentosum group F. EMBO J 1993, 12:3693-3701. 413646, 8253091.
45. Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick SM. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. DNA Repair (Amst) 2010, 9:745-753.
46. van Duin M, de Wit J, Odijk H, Westerveld A, Yasui A, Koken MH, Hoeijmakers JH, Bootsma D. Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell 1986, 44:913-923. 10.1016/0092-8674(86)90014-0, 2420469.
47. Boulikas T. Nuclear import of DNA repair proteins. Anticancer Res 1997, 17:843-863.
48. Ahmad A, Enzlin JH, Bhagwat NR, Wijgers N, Raams A, Appledoorn E, Theil AF, Hoeijmakers JH J, Vermeulen W, Jaspers NG J, Schärer OD, Niedernhofer LJ. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients. PLoS Genet 2010, 6:e1000871. 10.1371/journal.pgen.1000871, 2832669, 20221251.
49. Dingwall C, Laskey RA. Nuclear targeting sequences-a consensus?. Trends Biochem Sci 1991, 16:478-481.
50. Roberts JA, Bell SD, White MF. An archaeal XPF repair endonuclease dependent on a heterotrimeric PCNA. Mol Microbiol 2003, 48:361-371. 10.1046/j.1365-2958.2003.03444.x, 12675797.
51. Hutton RD, Craggs TD, White MF, Penedo JC. PCNA and XPF cooperate to distort DNA substrates. Nucleic Acids Res 2010, 38:1664-1675. 10.1093/nar/gkp1104, 2836553, 20008103.
52. Kim BJ, Lee H. Lys-110 is essential for targeting PCNA to replication and repair foci, and the K110A mutant activates apoptosis. Biol Cell 2008, 100:675-686. 10.1042/BC20070158, 2878812, 18498247.
53. Wang C, Lambert MW. The Fanconi anemia protein, FANCG, binds to the ERCC1-XPF endonuclease via its tetratricopeptide repeats and the central domain of ERCC1. Biochemistry 2010, 49:5560-5569. 10.1021/bi100584c, 2905376, 20518486.
54. Garcia-Higuera I, Kuang Y, Denham J, D'Andrea AD. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 2000, 96:3224-3230.
55. Lan L, Hayashi T, Rabeya RM, Nakajima S, Kanno S, Takao M, Matsunaga T, Yoshino M, Ichikawa M, Riele H, Tsuchiya S, Tanaka K, Yasui A. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells. DNA Repair (Amst) 2004, 3:135-143.
56. Hayes AP, Sevi LA, Feldt MC, Rose MD, Gammie AE. Reciprocal regulation of nuclear import of the yeast MutSalpha DNA mismatch repair proteins Msh2 and Msh6. DNA Repair (Amst) 2009, 8:739-751.
57. Li L, Peterson CA, Lu X, Legerski RJ. Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair. Mol Cell Biol 1995, 15:1993-1998. 230426, 7891694.
58. Orelli B, McClendon TB, Tsodikov OV, Ellenberger T, Niedernhofer LJ, Schärer OD. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways. J Biol Chem 2010, 285:3705-3712. 10.1074/jbc.M109.067538, 2823511, 19940136.
59. Miyamoto I, Miura N, Niwa H, Miyazaki J, Tanaka K. Mutational analysis of the structure and function of the xeroderma pigmentosum group A complementing protein. Identification of essential domains for nuclear localization and DNA excision repair. J Biol Chem 1992, 267:12182-12187.
60. Loeb LA. Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer 2011, 11:450-457. 10.1038/nrc3063, 21593786.
61. Payne CM, Holubec H, Crowley-Skillicorn C, Nguyen H, Bernstein H, Wilcox G, Bernstein C. Maspin is a deoxycholate-inducible, anti-apoptotic stress-response protein differentially expressed during carcinogenesis. Clin Exp Gastroenterol 2011, 4:239-253. 3234125, 22162927.
62. Leung M, Rosen D, Fields S, Cesano A, Budman DR. Poly(ADP-ribose) polymerase-1 inhibition: preclinical and clinical development of synthetic lethality. Mol Med 2011, 17:854-862. 3146606, 21424107.